Knott David M Jr Syndax Pharmaceuticals Inc Transaction History
Knott David M Jr
- $160 Million
- Q1 2025
A detailed history of Knott David M Jr transactions in Syndax Pharmaceuticals Inc stock. As of the latest transaction made, Knott David M Jr holds 128,000 shares of SNDX stock, worth $1.61 Million. This represents 0.99% of its overall portfolio holdings.
Number of Shares
128,000
Previous 128,000
-0.0%
Holding current value
$1.61 Million
Previous $1.69 Million
7.03%
% of portfolio
0.99%
Previous 0.98%
Shares
4 transactions
Others Institutions Holding SNDX
# of Institutions
238Shares Held
101MCall Options Held
1.36MPut Options Held
618K-
Kynam Capital Management, LP Princeton, NJ8.52MShares$107 Million8.82% of portfolio
-
Black Rock Inc. New York, NY7.91MShares$99.4 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.87MShares$61.2 Million0.0% of portfolio
-
Eversept Partners, LP New York, NY4.21MShares$52.9 Million5.73% of portfolio
-
Steven Cohen Point72 Asset Management, L.P. | Stamford, Ct4.01MShares$50.4 Million0.12% of portfolio
About Syndax Pharmaceuticals Inc
- Ticker SNDX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 56,565,200
- Market Cap $711M
- Description
- Syndax Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of cancer. Its lead product candidates are SNDX-5613, which is in phase 1/2 clinical trial targeting the binding interaction of Menin with the mixed lineage leukemia 1 protein for the treatment of MLL-rearranged (MLLr) and nucleophosmin...